Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) Interest Expenses (2022 - 2025)

Historic Interest Expenses for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to $127070.0.

  • HCW Biologics' Interest Expenses fell 4452.5% to $127070.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $848835.0, marking a year-over-year increase of 11916.67%. This contributed to the annual value of $631137.0 for FY2024, which is 12298.35% up from last year.
  • Latest data reveals that HCW Biologics reported Interest Expenses of $127070.0 as of Q3 2025, which was down 4452.5% from $228714.0 recorded in Q2 2025.
  • Over the past 5 years, HCW Biologics' Interest Expenses peaked at $255822.0 during Q1 2025, and registered a low of -$1423.0 during Q4 2023.
  • Its 4-year average for Interest Expenses is $137271.8, with a median of $111292.0 in 2023.
  • In the last 5 years, HCW Biologics' Interest Expenses plummeted by 10150.62% in 2023 and then surged by 1677104.71% in 2024.
  • Quarter analysis of 4 years shows HCW Biologics' Interest Expenses stood at $94476.0 in 2022, then crashed by 101.51% to -$1423.0 in 2023, then surged by 16771.05% to $237229.0 in 2024, then crashed by 46.44% to $127070.0 in 2025.
  • Its Interest Expenses stands at $127070.0 for Q3 2025, versus $228714.0 for Q2 2025 and $255822.0 for Q1 2025.